English

RESEARCH PHARMACEUTICAL SERVICES, INC.

EDGAR

Quarterly report (10-Q) · filed 2010-11-05

14 filing records in this dataset, filed from 2008-03-20 to 2010-11-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

76.3 million USD

2010-09-30 · USD

Exact inputs and evidence

Revenue: 76343880 USD Source

Operating margin

6.14%

2010-09-30 · %

Exact inputs and evidence

Operating Income: 4685241 USD Source
Revenue: 76343880 USD Source

Operating cash flow

-2.61 million USD

2010-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1722111 USD Source
Operating Cash Flow: 892650 USD Source

Free cash flow

-3.67 million USD

2010-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1722111 USD Source
Operating Cash Flow: 892650 USD Source
Capital Expenditure: 2106013 USD Source
Capital Expenditure: 1051447 USD Source

Cash and cash equivalents: 6.71 million USD 2010-09-30 Source
Exact value

6714464 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

277 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Revenue: 224167978 USD · 2009-01-01 – 2009-12-31 Source
Revenue: 161902947 USD · 2009-01-01 – 2009-09-30 Source
Revenue: 64710396 USD · 2010-01-01 – 2010-03-31 Source
Revenue: 73198782 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 76343880 USD · 2010-07-01 – 2010-09-30 Source

Net income

4.11 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Net income: 2620448 USD · 2009-01-01 – 2009-12-31 Source
Net income: 1982762 USD · 2009-01-01 – 2009-09-30 Source
Net income: -72734 USD · 2010-01-01 – 2010-03-31 Source
Net income: 1528730 USD · 2010-04-01 – 2010-06-30 Source
Net income: 2017614 USD · 2010-07-01 – 2010-09-30 Source

Operating cash flow

-695 thousand USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: -743549 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: -1770913 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -1570267 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 892650 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -1570267 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -1722111 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: 892650 USD · 2010-01-01 – 2010-06-30 Source

Capital expenditure

3.21 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Capital expenditure: 2680376 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 1574894 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 515967 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 1051447 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 515967 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 2106013 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 1051447 USD · 2010-01-01 – 2010-06-30 Source

Free cash flow

-3.91 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: -743549 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: -1770913 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -1570267 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 892650 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -1570267 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -1722111 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: 892650 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 2680376 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 1574894 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 515967 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 1051447 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 515967 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 2106013 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 1051447 USD · 2010-01-01 – 2010-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-11-05.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2009-12-31
Operating income: 5 of 11 periods available· newest 2009-12-31
Net income: 5 of 11 periods available· newest 2009-12-31
Operating cash flow: 5 of 11 periods available· newest 2009-12-31
Capital expenditure: 5 of 11 periods available· newest 2009-12-31
Total assets: 4 of 11 periods available· newest 2009-12-31
Total liabilities: 4 of 11 periods available· newest 2009-12-31
Current assets: 4 of 11 periods available· newest 2009-12-31
Current liabilities: 4 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+28.1%

Prior period

USD 175.05 million

2008-01-01 – 2008-12-31
Current period

USD 224.17 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

224167978 − 175052072 = 49115906 USD

175052072 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
224167978 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Year-over-year change in Revenue: 49115906 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 224167978 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#5188 Input fundies:Revenue: 175052072 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#5188
The citation records this snapshot. The page link may show a newer release later.
Net income
-30%

Prior period

USD 3.74 million

2008-01-01 – 2008-12-31
Current period

USD 2.62 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

2620448 − 3742784 = -1122336 USD

3742784 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
2620448 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Year-over-year change in Net income: -1122336 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 2620448 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8010 Input fundies:NetIncome: 3742784 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8010
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.02 million

Prior period

−USD 2.77 million

2008-01-01 – 2008-12-31
Current period

−USD 743,549

2009-01-01 – 2009-12-31

Exact inputs and evidence

-743549 − -2765051 = 2021502 USD

-2765051 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-743549 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Year-over-year change in Operating cash flow: 2021502 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -743549 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 Input fundies:OperatingCashFlow: -2765051 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+111.2%

Prior period

USD 1.27 million

2008-01-01 – 2008-12-31
Current period

USD 2.68 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

2680376 − 1269245 = 1411131 USD

1269245 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
2680376 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Year-over-year change in Capital expenditure: 1411131 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2680376 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 Input fundies:CapitalExpenditure: 1269245 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 224.17 million 100% of revenue
Operating costs Derived USD 217.43 million 97% of revenue
Operating income USD 6.74 million 3% of revenue
Tax, interest and other Derived USD 4.12 million 1.8% of revenue
Net income USD 2.62 million 1.2% of revenue

Cash

Operating cash flow −USD 743,549 −0.3% of revenue
Capital expenditure USD 2.68 million 1.2% of revenue
Free cash flow Derived −USD 3.42 million −1.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Operating loss: operating costs were 101% of revenue.
2006 97%
2007 Net loss: net income was −1.8% of revenue.
2008 96%
2009 97%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	70873388	71429097 Derived	-555709	1127370 Derived	-1683079	-1585075 Derived	Source 2005-01-01 – 2005-12-31: 70873388 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -555709 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -1683079 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -1307756 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 277319 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	94690733	91609082 Derived	3081651	1289685 Derived	1791966	-4418530 Derived	Source 2006-01-01 – 2006-12-31: 94690733 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 3081651 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 1791966 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -3771275 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 647255 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	134383243	129504612 Derived	4878631	7293972 Derived	-2415341	-585431 Derived	Source 2007-01-01 – 2007-12-31: 134383243 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 4878631 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -2415341 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 1612677 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2198108 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	175052072	168832619 Derived	6219453	2476669 Derived	3742784	-4034296 Derived	Source 2008-01-01 – 2008-12-31: 175052072 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 6219453 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 3742784 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -2765051 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1269245 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	224167978	217425617 Derived	6742361	4121913 Derived	2620448	-3423925 Derived	Source 2009-01-01 – 2009-12-31: 224167978 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 6742361 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 2620448 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -743549 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 2680376 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 224.2M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	70873388	Revenue: 70873388 Open source
20062006-12-31	Revenue	94690733	Revenue: 94690733 Open source
20072007-12-31	Revenue	134383243	Revenue: 134383243 Open source
20082008-12-31	Revenue	175052072	Revenue: 175052072 Open source
20092009-12-31	Revenue	224167978	Revenue: 224167978 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

28.1% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 70873388 Open source
20062006-12-31	Year over year	33.6%	Revenue: 94690733 Open source Revenue: 70873388 Open source
20072007-12-31	Year over year	41.9%	Revenue: 134383243 Open source Revenue: 94690733 Open source
20082008-12-31	Year over year	30.3%	Revenue: 175052072 Open source Revenue: 134383243 Open source
20092009-12-31	Year over year	28.1%	Revenue: 224167978 Open source Revenue: 175052072 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3% 2009

Net margin 1.2% 2009

Free cash flow margin -1.5% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Operating margin	-0.8%	Operating Income: -555709 Open source Revenue: 70873388 Open source
20062006-12-31	Operating margin	3.3%	Operating Income: 3081651 Open source Revenue: 94690733 Open source
20072007-12-31	Operating margin	3.6%	Operating Income: 4878631 Open source Revenue: 134383243 Open source
20082008-12-31	Operating margin	3.6%	Operating Income: 6219453 Open source Revenue: 175052072 Open source
20092009-12-31	Operating margin	3%	Operating Income: 6742361 Open source Revenue: 224167978 Open source
20052005-12-31	Net margin	-2.4%	Net Income: -1683079 Open source Revenue: 70873388 Open source
20062006-12-31	Net margin	1.9%	Net Income: 1791966 Open source Revenue: 94690733 Open source
20072007-12-31	Net margin	-1.8%	Net Income: -2415341 Open source Revenue: 134383243 Open source
20082008-12-31	Net margin	2.1%	Net Income: 3742784 Open source Revenue: 175052072 Open source
20092009-12-31	Net margin	1.2%	Net Income: 2620448 Open source Revenue: 224167978 Open source
20052005-12-31	Free cash flow margin	-2.2%	Revenue: 70873388 Open source Operating Cash Flow: -1307756 Open source Capital Expenditure: 277319 Open source
20062006-12-31	Free cash flow margin	-4.7%	Revenue: 94690733 Open source Operating Cash Flow: -3771275 Open source Capital Expenditure: 647255 Open source
20072007-12-31	Free cash flow margin	-0.4%	Revenue: 134383243 Open source Operating Cash Flow: 1612677 Open source Capital Expenditure: 2198108 Open source
20082008-12-31	Free cash flow margin	-2.3%	Revenue: 175052072 Open source Operating Cash Flow: -2765051 Open source Capital Expenditure: 1269245 Open source
20092009-12-31	Free cash flow margin	-1.5%	Revenue: 224167978 Open source Operating Cash Flow: -743549 Open source Capital Expenditure: 2680376 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -743.5K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	-1307756	Operating Cash Flow: -1307756 Open source
20062006-12-31	Operating cash flow	-3771275	Operating Cash Flow: -3771275 Open source
20072007-12-31	Operating cash flow	1612677	Operating Cash Flow: 1612677 Open source
20082008-12-31	Operating cash flow	-2765051	Operating Cash Flow: -2765051 Open source
20092009-12-31	Operating cash flow	-743549	Operating Cash Flow: -743549 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.4M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	-1585075	Operating Cash Flow: -1307756 Open source Capital Expenditure: 277319 Open source
20062006-12-31	Free cash flow	-4418530	Operating Cash Flow: -3771275 Open source Capital Expenditure: 647255 Open source
20072007-12-31	Free cash flow	-585431	Operating Cash Flow: 1612677 Open source Capital Expenditure: 2198108 Open source
20082008-12-31	Free cash flow	-4034296	Operating Cash Flow: -2765051 Open source Capital Expenditure: 1269245 Open source
20092009-12-31	Free cash flow	-3423925	Operating Cash Flow: -743549 Open source Capital Expenditure: 2680376 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

51.9% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Liabilities / assets	Not reported	No source recorded
20062006-12-31	Liabilities / assets	86%	Total Liabilities: 22472437 Open source Total Assets: 26124310 Open source
20072007-12-31	Liabilities / assets	39.6%	Total Liabilities: 19989670 Open source Total Assets: 50419019 Open source
20082008-12-31	Liabilities / assets	51.4%	Total Liabilities: 44806140 Open source Total Assets: 87088542 Open source
20092009-12-31	Liabilities / assets	51.9%	Total Liabilities: 49954662 Open source Total Assets: 96260678 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.46× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Current assets / current liabilities	Not reported	No source recorded
20062006-12-31	Current assets / current liabilities	1.37×	Current Assets: 24419883 Open source Current Liabilities: 17817379 Open source
20072007-12-31	Current assets / current liabilities	3.12×	Current Assets: 46171468 Open source Current Liabilities: 14816808 Open source
20082008-12-31	Current assets / current liabilities	1.69×	Current Assets: 60386186 Open source Current Liabilities: 35778428 Open source
20092009-12-31	Current assets / current liabilities	1.46×	Current Assets: 68449790 Open source Current Liabilities: 46848614 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 1.68 million Exact value Exact value: -1683079 USD 2005-01-01 – 2005-12-31: -1683079 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2005-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Net Income: -1683079 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1683079 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-08-000772.txt#8257 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1307756 USD 2005-01-01 – 2005-12-31: -1307756 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2005-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Operating Cash Flow: -1307756 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1307756 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-08-000772.txt#8518 The citation records this snapshot. The page link may show a newer release later.	USD 277,319 Exact value Exact value: 277319 USD 2005-01-01 – 2005-12-31: 277319 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2005-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Capital Expenditure: 277319 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 277319 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-08-000772.txt#8578 The citation records this snapshot. The page link may show a newer release later.	−USD 1.59 million Calculation and evidence -1307756 − 277319 USD Exact free cash flow: -1585075 USD 2005-01-01 – 2005-12-31: -1307756 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 277319 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2005-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Free cash flow: -1585075 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1307756 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-08-000772.txt#8518 Input fundies:CapitalExpenditure: 277319 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-08-000772.txt#8578 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 1.79 million Exact value Exact value: 1791966 USD 2006-01-01 – 2006-12-31: 1791966 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2006-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Net Income: 1791966 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1791966 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-09-000701.txt#8260 The citation records this snapshot. The page link may show a newer release later.	−USD 3.77 million Exact value Exact value: -3771275 USD 2006-01-01 – 2006-12-31: -3771275 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2006-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Operating Cash Flow: -3771275 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3771275 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-09-000701.txt#8491 The citation records this snapshot. The page link may show a newer release later.	USD 647,255 Exact value Exact value: 647255 USD 2006-01-01 – 2006-12-31: 647255 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2006-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Capital Expenditure: 647255 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 647255 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-09-000701.txt#8568 The citation records this snapshot. The page link may show a newer release later.	−USD 4.42 million Calculation and evidence -3771275 − 647255 USD Exact free cash flow: -4418530 USD 2006-01-01 – 2006-12-31: -3771275 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 647255 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2006-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Free cash flow: -4418530 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3771275 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-09-000701.txt#8491 Input fundies:CapitalExpenditure: 647255 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000893220-09-000701.txt#8568 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 2.42 million Exact value Exact value: -2415341 USD 2007-01-01 – 2007-12-31: -2415341 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2007-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Net Income: -2415341 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2415341 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8010 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Exact value Exact value: 1612677 USD 2007-01-01 – 2007-12-31: 1612677 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2007-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Operating Cash Flow: 1612677 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1612677 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 The citation records this snapshot. The page link may show a newer release later.	USD 2.2 million Exact value Exact value: 2198108 USD 2007-01-01 – 2007-12-31: 2198108 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2007-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Capital Expenditure: 2198108 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2198108 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.	−USD 585,431 Calculation and evidence 1612677 − 2198108 USD Exact free cash flow: -585431 USD 2007-01-01 – 2007-12-31: 1612677 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2198108 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2007-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Free cash flow: -585431 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1612677 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 Input fundies:CapitalExpenditure: 2198108 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 3.74 million Exact value Exact value: 3742784 USD 2008-01-01 – 2008-12-31: 3742784 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2008-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Net Income: 3742784 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3742784 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8010 The citation records this snapshot. The page link may show a newer release later.	−USD 2.77 million Exact value Exact value: -2765051 USD 2008-01-01 – 2008-12-31: -2765051 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2008-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Operating Cash Flow: -2765051 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2765051 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 The citation records this snapshot. The page link may show a newer release later.	USD 1.27 million Exact value Exact value: 1269245 USD 2008-01-01 – 2008-12-31: 1269245 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2008-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Capital Expenditure: 1269245 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1269245 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.	−USD 4.03 million Calculation and evidence -2765051 − 1269245 USD Exact free cash flow: -4034296 USD 2008-01-01 – 2008-12-31: -2765051 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1269245 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2008-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Free cash flow: -4034296 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2765051 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 Input fundies:CapitalExpenditure: 1269245 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 2.62 million Exact value Exact value: 2620448 USD 2009-01-01 – 2009-12-31: 2620448 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Net Income: 2620448 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2620448 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8010 The citation records this snapshot. The page link may show a newer release later.	−USD 743,549 Exact value Exact value: -743549 USD 2009-01-01 – 2009-12-31: -743549 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Operating Cash Flow: -743549 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -743549 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 The citation records this snapshot. The page link may show a newer release later.	USD 2.68 million Exact value Exact value: 2680376 USD 2009-01-01 – 2009-12-31: 2680376 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Capital Expenditure: 2680376 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2680376 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.	−USD 3.42 million Calculation and evidence -743549 − 2680376 USD Exact free cash flow: -3423925 USD 2009-01-01 – 2009-12-31: -743549 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 2680376 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESEARCH PHARMACEUTICAL SERVICES, INC. · 2009-12-31 RESEARCH PHARMACEUTICAL SERVICES, INC. (edgar:1420070) Free cash flow: -3423925 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:25:19Z Snapshot: 33b7b66a2889735d7e6538515fbe4e4423834f951686ab8f023d7cbbe0d308cf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420070?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -743549 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8218 Input fundies:CapitalExpenditure: 2680376 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420070/0000950123-10-027588.txt#8294 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001420070, 1420070, edgar:1420070

RESEARCH PHARMACEUTICAL SERVICES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation